Fatal Reactivation of Occult Hepatitis B Virus Infection after Rituximab and Chemotherapy in Lymphoma: Necessity of Antiviral Prophylaxis

Publisher： Karger

E-ISSN： 2296-5262|33|10|537-539

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.10, 2010-09, pp. : 537-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy of Occult Hepatitis B Virus Infection and Prevention of Reactivation

Intervirology, Vol. 57, Iss. 3-4, 2014-07 ,pp. : 189-195

Karger

Access to resources Recommend Favorite

Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 198-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis B Virus Reactivation in a Primary Central Nervous System Lymphoma Patient following Intrathecal Rituximab Treatment

Acta Haematologica, Vol. 125, Iss. 3, 2010-12 ,pp. : 121-124

Karger

Access to resources Recommend Favorite

Occult hepatitis B virus infection predicts de novo hepatitis B infection in patients with alcoholic cirrhosis after liver transplantation

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 897-904

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fatal Interruption of a 3TC-containing Regimen in a HIV-infected Patient Due to Re-activation of Chronic Hepatitis B Virus Infection

By Sellier Pierre Clevenbergh Philippe Mazeron Marie-christine Cazals-hatem Dominique Evans John Cervoni Jeanine Badsi Esma Bendenoun Marc Diemer Myriam Vincent Valerie Caulin Charles Bergmann Jean-francois

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 6-7, 2004-07 ,pp. : 533-535

Informa Healthcare

Access to resources Recommend Favorite